Dr Reddy's

Dr. Reddy's (RDY) to Report Q4 Earnings: What's in Store?
Dr. Reddy's (RDY) to Report Q4 Earnings: What's in Store?
Yahoo/Zacks.com
Dr Reddy's
earnings
Flag link:
Dr Reddy's acquires a portfolio of 42 ANDAs in US
Dr Reddy's acquires a portfolio of 42 ANDAs in US
Economic Times, India
Dr Reddy's
FDA
Flag link:
US court rejects Indivior’s appeal on Suboxone generic version
US court rejects Indivior’s appeal on Suboxone generic version
Pharmaceutical Business Review
Indivior
generics
Suboxone Film
Dr Reddy's
opioid addiction
Flag link:
Celgene's Revlimid defenses withstand another challenge
Celgene's Revlimid defenses withstand another challenge
Biopharma Dive
Celgene
Revlimid
Multiple Myeloma
Dr Reddy's
patents
Flag link:
U.S. court allows generic version of Indivior opioid abuse drug
U.S. court allows generic version of Indivior opioid abuse drug
Reuters
Dr Reddy's
Indivior
Suboxone Film
Flag link:
Repeat violations stack up at Dr. Reddy's cancer drug plant
Repeat violations stack up at Dr. Reddy's cancer drug plant
Fierce Pharma
Dr Reddy's
India
FDA
drug manufacturing
Flag link:
Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
earnings
biotech
Biogen
Alexion Pharmaceuticals
Bristol-Myers Squibb
Celgene
Gilead Sciences
Merck
Biomarin
Galapagos
Seattle Genetics
Dr Reddy's
Flag link:
Dr Reddy's sells off Tennessee antibiotics facility in restructuring push
Dr Reddy's sells off Tennessee antibiotics facility in restructuring push
Biopharma Dive
Dr Reddy's
India
Tennessee
drug manufacturing
Flag link:
Teva holding off launch of opioid addiction drug
Teva holding off launch of opioid addiction drug
Pharmaforum
Teva Pharmaceutical
opioids
opioid addiction
generics
Dr Reddy's
Suboxone
Indivior
Flag link:
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Reuters
Indivior
opioid addiction
generics
Suboxone Film
Dr Reddy's
Flag link:
U.S. District Court rules in favor of Lilly's Alimta patent
U.S. District Court rules in favor of Lilly's Alimta patent
Yahoo/Reuters
Eli Lilly
Alimta
Hospira
Dr Reddy's
generics
patents
Flag link:
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
CP Wire
Individor
Suboxone Film
patents
Dr Reddy's
Actavis
Par Pharmaceutical
Teva Pharmaceutical
Alvogen
Flag link:
The difficult momentum of Indian pharma sector
The difficult momentum of Indian pharma sector
GoinPharma
India
generics
Sun Pharma
Cipla
Dr Reddy's
Lupin
Flag link:
Dr. Reddy's sells off psoriasis candidate in out-licensing deal
Dr. Reddy's sells off psoriasis candidate in out-licensing deal
BioPharma Dive
Dr Reddy's
psoriasis
out-licensing
DFD-06
Encore Dermatology
Flag link:
Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns
Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns
Fierce Pharma
Dr Reddy's
Novartis
OTC
drug ads
Flag link:
7 Pharma Plays With Emerging Market Potential
7 Pharma Plays With Emerging Market Potential
Barron's
emerging markets
Pfizer
GSK
Sanofi
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Dr Reddy's
Flag link:
BioMarin sues to stop generic version of its $90K-a-year drug
BioMarin sues to stop generic version of its $90K-a-year drug
Bizjournals.com
Biomarin
generics
Kuvan
Dr Reddy's
Flag link:
Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US
Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US
Yahoo
Dr Reddy's
generics
osteoporosis
Eli Lilly
Evista
Flag link:
Dr Reddy's and Amgen broaden marketing collaboration
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Amgen
Dr Reddy's
India
Xgeva
Prolia
Vectibix
Flag link:
Dr. Reddy's breaks off marketing partnership with Glaxo
Dr. Reddy's breaks off marketing partnership with Glaxo
BioPharma Dive
Dr Reddy's
GSK
emerging markets
India
Flag link:

Pages